Scott M. Storer

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Scott M.
Storer held former positions as Vice President-Bio Science Finance at Baxter International, Inc., Senior Vice President-Finance at Baxalta, Inc., and Chief Financial Officer & Senior Vice President at Momenta Pharmaceuticals, Inc. He earned an MBA from Kellogg School of Management and an undergraduate degree from the University of Colorado Boulder.

Precedenti posizioni note di Scott M. Storer

Società	Posizione	Fine
MOMENTA PHARMACEUTICALS, INC.	Direttore Finanziario/CFO	08/05/2018
BAXTER INTERNATIONAL INC.	Corporate Officer/Principal	-
BAXALTA INC	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Scott M. Storer

Formazione di Scott M. Storer

Kellogg School of Management	Masters Business Admin
University of Colorado Boulder	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Scott M. Storer

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BAXTER INTERNATIONAL INC.	Health Technology

Aziende private	2
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.	Health Technology
Baxalta, Inc. Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL.	Health Technology